Previous 10 | Next 10 |
Positive Pivotal Top-Line data EyeGate Pharmaceuticals, Inc . ( EYEG ) is a clinical stage specialty pharmaceutical company that develops products for treating eye diseases and disorders. On Nov 22, 2019, EYEG announced that their PRK (photorefractive keratectomy) study has met its pr...
These Penny Stocks Raced Higher On Friday But Can They Maintain The Trend Next Week? After all of the major markets took a slight dip yesterday, they all seem to be in the green to start off November 22nd’s trading session. It is a strong look for the markets to show some corrections an...
Gainers: EyeGate Pharmaceuticals (NASDAQ: EYEG ) +43% . More news on: EyeGate Pharmaceuticals, Inc., Stage Stores, Inc., Cancer Genetics, Inc., Stocks on the move, Read more ...
EyeGate Pharmaceuticals (NASDAQ: EYEG ) +84% on achieving primary endpoint in PRK pivotal study. More news on: EyeGate Pharmaceuticals, Inc., Viveve Medical, Inc., Hibbett Sports, Inc., Stocks on the move, Read more ...
EyeGate Pharmaceuticals' (NASDAQ: EYEG ) Ocular Bandage Gel eye drop achieves primary endpoint in PRK pivotal study. More news on: EyeGate Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
WALTHAM, MA / ACCESSWIRE / November 22, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received select topline data, specifically the prima...
WALTHAM, MA / ACCESSWIRE / November 7, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, today announced financial results for the quarter ended September 30, 2019 and pr...
Thinly traded nano cap EyeGate Pharmaceuticals ( EYEG +22.4% ) is up on almost a 4x surge in volume, albeit on turnover of only 82K shares, on no particular news. More news on: EyeGate Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers: Communications Systems (NASDAQ: JCS ) +27% . Zovio (NASDAQ: ZVO ) +19% . CRA International (NASDAQ: CRAI ) +19% . PolarityTE (NASDAQ: PTE ) +18% . Ducommun Incorporated (NYSE: DCO ) +17% . Murphy USA (NYSE: MUSA ) +17% . Dawson Geophysical (NASDAQ: DWSN ) +17% . EyeGa...
WALTHAM, MA / ACCESSWIRE / October 9, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has completed randomization for its corneal wound repair p...
News, Short Squeeze, Breakout and More Instantly...
Eyegate Pharmaceuticals Inc. Company Name:
EYEG Stock Symbol:
NASDAQ Market:
LONDON, UK / ACCESSWIRE / December 9, 2022 / Kazia Therapeutics has announced the publication of pre-clinical data for its second pipeline asset, EVT801 in the journal Cancer Research Communications. The research was conducted by licensing partner Evotec and was the key driver for Kazia in-licen...
LONDON, UK / ACCESSWIRE / December 7, 2022 / With its H123 interim results, ReNeuron highlighted progress across its proprietary exosome platform, CustomEx. The company reported H123 revenues of £438k (H122: £58k), primarily related to income associated with a £320k payment from F...
WALTHAM, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announc...